125 related articles for article (PubMed ID: 7694879)
1. Metabolic effects of cyclosporin A and FK 506 in liver transplant recipients.
Krentz AJ; Dousset B; Mayer D; McMaster P; Buckels J; Cramb R; Smith JM; Nattrass M
Diabetes; 1993 Dec; 42(12):1753-9. PubMed ID: 7694879
[TBL] [Abstract][Full Text] [Related]
2. Metabolic and hormonal effects of tacrolimus (FK506) or cyclosporin immunosuppression following renal transplantation.
Dmitrewski J; Krentz AJ; Mayer AD; Buckels JA; Barnes AD; Smith J; Nattrass M
Diabetes Obes Metab; 2001 Aug; 3(4):287-92. PubMed ID: 11520309
[TBL] [Abstract][Full Text] [Related]
3. Serum lipids and apolipoproteins in liver transplant recipients: a comparative study of cyclosporin A and FK 506.
Krentz AJ; Cramb R; Dousset B; Mayer D; McMaster P; Buckels J; Smith JM; Nattrass M
J Lab Clin Med; 1994 Sep; 124(3):381-5. PubMed ID: 7521895
[TBL] [Abstract][Full Text] [Related]
4. Regulation of glucose tolerance in patients after liver transplantation: impact of cyclosporin versus tacrolimus therapy.
Konrad T; Steinmüller T; Vicini P; Toffolo G; Grewerus D; Schüller A; Bechstein WO; Usadel KH; Cobelli C; Neuhaus P
Transplantation; 2000 May; 69(10):2072-8. PubMed ID: 10852599
[TBL] [Abstract][Full Text] [Related]
5. Effect of obesity on circulating intermediary metabolite concentrations in the absence of impaired glucose tolerance.
Robertson DA; Singh BM; Nattrass M
Int J Obes; 1991 Oct; 15(10):635-45. PubMed ID: 1752724
[TBL] [Abstract][Full Text] [Related]
6. The effects of maintenance doses of FK506 versus cyclosporin A on glucose and lipid metabolism after orthotopic liver transplantation.
Fernandez LA; Lehmann R; Luzi L; Battezzati A; Angelico MC; Ricordi C; Tzakis A; Alejandro R
Transplantation; 1999 Nov; 68(10):1532-41. PubMed ID: 10589951
[TBL] [Abstract][Full Text] [Related]
7. Abnormal regulation of carbohydrate metabolism in motor neurone disease.
Krentz AJ; Williams AC; Nattrass M
Diabetes Res; 1991 Feb; 16(2):93-9. PubMed ID: 1817811
[TBL] [Abstract][Full Text] [Related]
8. Impaired glucose tolerance is characterized by multiple abnormalities in the regulation of intermediary metabolism.
Krentz AJ; Singh BM; Nattrass M
Diabet Med; 1991 Nov; 8(9):848-54. PubMed ID: 1837511
[TBL] [Abstract][Full Text] [Related]
9. Glucose metabolism in liver transplant recipients treated with FK 506 or cyclosporin in the European multicentre study.
Ericzon B; Groth C; Bismuth H; Calne R; McMaster P; Neuhaus P; Otto G; Pichlmayr R; Williams R
Transpl Int; 1994; 7 Suppl 1():S11-4. PubMed ID: 11271178
[TBL] [Abstract][Full Text] [Related]
10. The effect of cyclosporine vs FK 506 on glucose metabolism.
Steinmueller T; Konrad T; Jonas S; Tullius S; Bechstein WO; Mueller A; Platz KP; Neumann U; Vicini P; Toffolo G; Cobelli C; Usadel KH; Neuhaus P
Transplant Proc; 1999; 31(1-2):1129-30. PubMed ID: 10083504
[No Abstract] [Full Text] [Related]
11. Abnormal regulation of intermediary metabolism after oral glucose ingestion in myotonic dystrophy.
Krentz AJ; Coles NH; Williams AC; Nattrass M
Metabolism; 1990 Sep; 39(9):938-42. PubMed ID: 2202885
[TBL] [Abstract][Full Text] [Related]
12. Basal intermediary metabolism in impaired glucose tolerance and morbid obesity.
Krentz AJ; Singh BM; Hale PJ; Robertson DA; Nattrass M
Diabetes Res; 1992; 20(3):51-60. PubMed ID: 1345002
[TBL] [Abstract][Full Text] [Related]
13. Metabolic abnormalities in obese patients with impaired glucose tolerance.
Robertson DA; Singh BM; Baddeley RM; Nattrass M
Diabet Med; 1990 Jan; 7(1):45-9. PubMed ID: 2137062
[TBL] [Abstract][Full Text] [Related]
14. Glucose metabolism following liver transplantation and immunosuppression with cyclosporine A or FK 506.
Senninger N; Golling M; Datsis K; Sido B; Herfarth C; Otto G
Transplant Proc; 1995 Feb; 27(1):1127-8. PubMed ID: 7533364
[No Abstract] [Full Text] [Related]
15. Conversion from Tacrolimus to Cyclosporine A Improves Glucose Tolerance in HCV-Positive Renal Transplant Recipients.
Handisurya A; Kerscher C; Tura A; Herkner H; Payer BA; Mandorfer M; Werzowa J; Winnicki W; Reiberger T; Kautzky-Willer A; Pacini G; Säemann M; Schmidt A
PLoS One; 2016; 11(1):e0145319. PubMed ID: 26735686
[TBL] [Abstract][Full Text] [Related]
16. Effect of CsA versus FK 506 on insulin sensitivity and insulin response using a modeling technique.
Steinmueller T; Konrad T; Vicini P; Toffolo G; Jonas S; Tullius S; Bechstein WO; Cobelli C; Usadel KH; Neuhaus P
Transplant Proc; 1998 Jun; 30(4):1452-3. PubMed ID: 9636589
[No Abstract] [Full Text] [Related]
17. Impaired glucose tolerance in obesity is associated with insensitivity to insulin in multiple aspects of metabolism as assessed by a low dose incremental insulin infusion technique.
Robertson DA; Singh BM; Nattrass M
Diabet Med; 1991 Oct; 8(8):718-25. PubMed ID: 1838062
[TBL] [Abstract][Full Text] [Related]
18. Normalization of hepatic glucose regulation despite systemic insulin delivery. Studies in patients with pancreatic transplantation for type 1 (insulin-dependent) diabetes mellitus.
Wilczek H; Gunnarsson R; Felig P; Ostman J; Groth CG; Wahren J
Diabetologia; 1991 May; 34(5):345-9. PubMed ID: 1864489
[TBL] [Abstract][Full Text] [Related]
19. Complete reversal of FK 506 induced diabetes in a liver transplant recipient by change of immunosuppression to cyclosporine A.
Kanzler S; Lohse AW; Schirmacher P; Hermann E; Otto G; Meyer zum Büschenfelde KH
Z Gastroenterol; 1996 Feb; 34(2):128-31. PubMed ID: 8659188
[TBL] [Abstract][Full Text] [Related]
20. Differences in gastric motor activity in renal transplant recipients treated with FK-506 versus cyclosporine.
Maes BD; Vanwalleghem J; Kuypers D; Ghoos Y; Rutgeerts PJ; Vanrenterghem YF
Transplantation; 1999 Nov; 68(10):1482-5. PubMed ID: 10589943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
